Image source: The Motley Fool. Teva Pharmaceutical Industries ( NYSE:TEVA ) Oct 27, 2021 , 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day, and thank you for standing by. Welcome to the Teva Pharmaceuticals third-quarter 2021 financial results conference call. [Operator instructions] Please be advised that today’s conference is being recorded. [Operator instructions] I would now like to hand the conference over to your first speaker today, Kevin Mannix, senior vice president of investor relations. Please go ahead. Kevin Mannix — Senior Vice President of Investor Relations Thank you, Nadia, and thanks, everyone, for joining us today to discuss Teva’s third-quarter 2021 financial results. Joining me on today’s call is Kare Schultz, Teva’s chief executive officer; Eli Kalif, chief financial officer; and Dr. Sven Dethlefs, Teva’s head of North America commercial. We hope you’ve had an opportunity to review our press release, which was issued about an hour ago. A copy of the release and the slides being presented on this call can be found on our website at www.tevapharm.com. Please note that the discussion on today’s call includes certain non-GAAP measures that is defined by the SEC. Management uses both GAAP… Read full this story
- 7 highlights of Tim Cook’s Q3 2017 financial call with analysts
- Drug Maker Goes Social to End Supply Chain Crisis
- NARCOTIC NATION: Should NJ sue Big Pharma over the rising opioid epidemic?
- 20 states sue six generic drugmakers over price fixing
- Jenny McArthy autism story
Teva Pharmaceutical Industries (TEVA) Q3 2021 Earnings Call Transcript have 246 words, post on www.fool.com at October 28, 2021. This is cached page on wBlogs. If you want remove this page, please contact us.